The Place of Immune Reconstitution Therapy in the Management of Relapsing Multiple Sclerosis in France: An Expert Consensus
Abstract The treatment strategy in relapsing multiple sclerosis (RMS) is a complex decision requiring individualization of treatment sequences to maximize clinical outcomes. Current local and international guidelines do not provide specific recommendation on the use of immune reconstitution therapy...
Main Authors: | Jerome De Sèze, Laurent Suchet, Claude Mekies, Eric Manchon, Pierre Labauge, Anne-Marie Guennoc, Gilles Defer, Pierre Clavelou, Giovanni Castelnovo, Bertrand Bourre, Caroline Bensa-Koscher, Abdullatif Al Khedr, Julie Le Mao, Lauriane Villemur, Stephane Bouée, Laura Luciani, Patrick Vermersch |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2022-12-01
|
Series: | Neurology and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s40120-022-00430-z |
Similar Items
-
Expert Narrative Review of the Safety of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis
by: Pierre Clavelou, et al.
Published: (2023-06-01) -
Immune reconstitution inflammatory syndrome‐associated lymphoma: A retrospective Brazilian cohort
by: Juliano Cordova Vargas, et al.
Published: (2024-02-01) -
Immune reconstitution inflammatory syndrome: A therapeutic paradox
by: Joan Felicita Samson, et al.
Published: (2012-01-01) -
Immune Reconstitution Therapy or Continuous Immunosuppression for the Management of Active Relapsing–Remitting Multiple Sclerosis Patients? A Narrative Review
by: Isa Ahmed AlSharoqi, et al.
Published: (2020-04-01) -
Reconstitution of the complete rupture in musculotendinous junction using skeletal muscle-derived multipotent stem cell sheet-pellets as a “bio-bond”
by: Hiroyuki Hashimoto, et al.
Published: (2016-07-01)